Pirsch J D, D'Alessandro A M, Sollinger H W, Hoffmann R M, Roecker E, Voss B J, Lorentzen D, Knechtle S J, Reed A, Kalayoglu M
Department of Medicine, University of Wisconsin School of Medicine, Madison 53792.
Transplantation. 1992 Jan;53(1):55-9. doi: 10.1097/00007890-199201000-00010.
We retrospectively analyzed 526 primary cadaver recipients transplanted at a single center to identify pretransplant variables that predict long-term survival with multivariate analysis. All recipients received at least three random blood transfusions and were treated under a quadruple-therapy protocol consisting of ALG, azathioprine, prednisone, and cyclosporine. Of 526 consecutive transplants, 86 grafts were lost from acute or chronic rejection. Thirteen grafts were lost for nonimmunologic reasons and 35 recipients died with a functioning graft. A total of 273 patients (52%) experienced at least one episode of acute rejection. Donor age ranged from 3 to 64 years, with 62% of donors less than 30 years of age and 9% of donors over 50 years of age. Donor age was not predictive of long-term graft survival and neither was the difference between donor and recipient age. Recipient age was predictive of subsequent immunologic graft less, with younger recipients at greater risk (P = 0.011). The rate of first rejection was also inversely related to recipient age, with younger recipients rejecting earlier (P = 0.0001). The degree of DR mismatch was the only other significant predictor of long-term graft success (P = 0.013). Transplant survival correlated with the degree of DR mismatch: 2 DR mismatch was the worst, 1 DR mismatch was intermediate and 0 DR mismatch was the best (P = 0.02). A, B, AB, and BDR did not influence long-term graft outcome. In our center, donor age does not predict graft failure. Younger recipients have a higher rate of early rejection and, combined with a poor DR match, are at higher risk for long-term graft failure.
我们回顾性分析了在单一中心接受移植的526例原发性尸体供肾受者,通过多因素分析确定预测长期存活的移植前变量。所有受者均接受至少3次随机输血,并按照由抗淋巴细胞球蛋白(ALG)、硫唑嘌呤、泼尼松和环孢素组成的四联疗法进行治疗。在526例连续移植中,86例移植物因急性或慢性排斥反应而丢失。13例移植物因非免疫原因丢失,35例受者在移植物功能良好时死亡。共有273例患者(52%)经历了至少1次急性排斥反应。供者年龄为3至64岁,62%的供者年龄小于30岁,9%的供者年龄超过50岁。供者年龄不能预测长期移植物存活,供者与受者年龄之差也不能预测。受者年龄可预测随后的免疫性移植物丢失较少,年轻受者风险更高(P = 0.011)。首次排斥反应的发生率也与受者年龄呈负相关,年轻受者排斥反应更早(P = 0.0001)。DR错配程度是长期移植物成功的唯一其他重要预测因素(P = 0.013)。移植存活率与DR错配程度相关:2个DR错配最差,1个DR错配居中,0个DR错配最佳(P = 0.02)。A、B、AB和BDR不影响长期移植物结局。在我们中心,供者年龄不能预测移植物失败。年轻受者早期排斥反应发生率较高,再加上DR配型不佳,长期移植物失败风险更高。